Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
20M
-
Shares change
-
+3.84M
-
Total reported value, excl. options
-
$282M
-
Value change
-
+$49M
-
Put/Call ratio
-
1.76
-
Number of buys
-
48
-
Number of sells
-
-23
-
Price
-
$14.06
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2015
85 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q3 2015.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20M shares
of 177M outstanding shares and own 11.33% of the company stock.
Largest 10 shareholders include FMR LLC (2.99M shares), Capital Research Global Investors (2.84M shares), Versant Venture Management, LLC (2.22M shares), Capital World Investors (2.03M shares), FEDERATED INVESTORS INC /PA/ (1.72M shares), Lamond Capital Partners LLC (1.23M shares), Polaris Venture Management Co. V, L.L.C. (1.23M shares), WELLINGTON MANAGEMENT GROUP LLP (916K shares), JENNISON ASSOCIATES LLC (770K shares), and Portolan Capital Management, LLC (492K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.